Doctors Note Logo

Published on: 3/18/2026

Humira Failed? Why Your Gut is Still Flaring + New Medical Next Steps

When Humira stops controlling your Crohn's disease, the first step is confirming active inflammation through bloodwork, stool tests, or imaging, then measuring Humira drug levels and antibodies. Low drug levels may respond to dose escalation or adding an immunomodulator like methotrexate, while high antibodies typically mean it's time to switch.

If Humira failure is confirmed, common next options include Stelara (ustekinumab) or Skyrizi (risankizumab), both targeting IL-23 pathways, with Entyvio (vedolizumab), Rinvoq (upadacitinib), or another anti-TNF as alternatives. The best choice depends on why Humira failed, your disease severity, location, fistulas, prior surgeries, and safety profile.

Because Crohn's flares can mimic other GI conditions—and the right next step hinges on what's actually driving your symptoms—it's worth getting clarity fast. Take a free, instant, online symptom check to help identify what's going on, organize your symptoms for your gastroenterologist, and confidently navigate your next treatment decision.

Reviewed for medical accuracy: 06/23/2026

answer background

Explanation

Humira Failed? Why Your Gut Is Still Flaring + New Medical Next Steps

If you're living with Crohn's disease and Humira (adalimumab) isn't working anymore — or never worked well in the first place — you're not alone. Many people eventually need to switch therapies. It's frustrating, especially if you had high hopes for relief.

The good news? You still have options. And in many cases, switching treatments can bring symptoms back under control.

Let's walk through why Humira may fail, what it means for your health, and the best medication for Crohn's when Humira fails, based on current medical evidence and treatment guidelines.


Why Would Humira Stop Working?

Humira is a biologic medication that blocks tumor necrosis factor (TNF), a key driver of inflammation in Crohn's disease. It's often one of the first advanced therapies doctors prescribe.

But it doesn't work for everyone — and even if it does at first, it may lose effectiveness over time.

There are three main reasons:

1. Primary Non-Response

This means Humira never worked well from the start. About 10–30% of patients fall into this category. Your body simply didn't respond to TNF-blocking therapy.

2. Secondary Loss of Response

Humira worked initially but stopped working later. This happens in up to 40% of patients over time.

Common causes include:

  • Your immune system forming antibodies against Humira
  • Drug levels in your blood dropping too low
  • The disease changing biologically

3. Inflammation That Isn't Crohn's

Not all flares are caused by active Crohn's inflammation. Symptoms can also be due to:

  • Irritable bowel syndrome (IBS)
  • Infection
  • Scar tissue (strictures)
  • Bile acid malabsorption

This is why doctors often check:

  • Drug levels
  • Antibody levels
  • Inflammatory markers (CRP, fecal calprotectin)
  • Imaging or colonoscopy results

Before switching medications, your doctor should confirm whether Humira truly failed or whether adjustments can be made.


First Step: Optimize Before Switching

Sometimes Humira hasn't actually failed — it just needs adjustment.

Your doctor may:

  • Increase the dose (weekly instead of every other week)
  • Check drug levels and antibodies
  • Add an immunomodulator like azathioprine or methotrexate
  • Rule out infection or other causes of symptoms

If drug levels are low without antibodies, increasing the dose may restore effectiveness.

If antibodies are present, switching medications is often necessary.


Best Medication for Crohn's When Humira Fails

If Humira truly isn't working, the next step depends on why it failed and your disease pattern.

Here are the main evidence-based options.


1. Switch to Another Anti-TNF (Sometimes)

If Humira stopped working due to antibodies — but you initially responded well — switching to another anti-TNF like:

  • Remicade (infliximab)
  • Cimzia (certolizumab)

can still work.

However, if you never responded to Humira at all (primary non-response), switching within the same class is less likely to help.


2. Stelara (Ustekinumab)

Stelara targets different inflammatory pathways (IL-12 and IL-23), not TNF.

Why doctors like it after Humira failure:

  • Works in patients who failed anti-TNF drugs
  • Good safety profile
  • Lower risk of serious infections compared to anti-TNFs
  • Convenient dosing (every 8 weeks after initial infusion)

Clinical trials show many patients achieve remission after switching to Stelara when anti-TNFs stop working.

For many patients, this becomes the best medication for Crohn's when Humira fails, especially after antibody development or primary non-response.


3. Skyrizi (Risankizumab)

Skyrizi targets IL-23 specifically and is one of the newer Crohn's treatments.

Benefits:

  • Strong remission rates in patients who failed anti-TNFs
  • Effective for moderate-to-severe disease
  • Increasingly used earlier in treatment algorithms

This is emerging as a leading option for patients who don't respond to TNF blockers.


4. Entyvio (Vedolizumab)

Entyvio works differently — it blocks gut-specific immune activity instead of suppressing the entire immune system.

Pros:

  • Gut-selective (less systemic immune suppression)
  • Lower infection risk
  • Good safety record

Cons:

  • May work more slowly
  • Sometimes less effective for severe or aggressive disease

For patients concerned about infection risk, this can be a strong alternative.


5. JAK Inhibitors (Rinvoq / Upadacitinib)

These are oral medications that work inside immune cells to block inflammation signals.

Benefits:

  • Fast symptom relief
  • Effective in patients who failed biologics

Risks:

  • Higher risk of blood clots in some patients
  • Requires close monitoring

These are typically reserved for moderate-to-severe cases after other biologics fail.


How Doctors Decide What's Next

There is no single "right" answer for everyone. The best medication for Crohn's when Humira fails depends on:

  • Whether you responded to Humira at all
  • Presence of antibodies
  • Disease location (small bowel vs colon)
  • Severity
  • Fistulas or strictures
  • Past surgeries
  • Your overall health
  • Insurance coverage

This decision should always be individualized.


What If It's Not Crohn's Causing Symptoms?

Sometimes persistent symptoms are not active Crohn's inflammation.

Your doctor may check:

  • Fecal calprotectin (stool inflammation marker)
  • CRP (blood inflammation marker)
  • MRI or CT enterography
  • Colonoscopy

If inflammation is low, your symptoms might be due to IBS overlap, scar tissue, or another condition. Since Crohn's and Ulcerative Colitis can sometimes be confused or overlap in presentation, checking your symptoms with a free assessment tool can help clarify whether your specific pattern warrants additional testing or consultation.


When Surgery Is Considered

If medications repeatedly fail or if complications develop, surgery may be recommended.

Reasons include:

  • Obstruction from scar tissue
  • Abscess
  • Fistulas not responding to therapy
  • Severe disease not controlled with biologics

Surgery is not a failure — for some patients, it significantly improves quality of life.


What You Should Do Now

If Humira isn't working:

  1. Ask your doctor to check drug levels and antibodies.
  2. Confirm whether inflammation is truly active.
  3. Discuss switching to:
    • Stelara
    • Skyrizi
    • Entyvio
    • Rinvoq
  4. Review risks and benefits clearly.
  5. Make a shared decision based on your goals and medical history.

A Balanced Perspective

It's discouraging when a medication fails. But modern Crohn's treatment has evolved significantly in the past decade. There are now multiple targeted therapies with different mechanisms of action.

Many patients achieve remission after switching.

What matters most is:

  • Not ignoring worsening symptoms
  • Not stopping medication without guidance
  • Working closely with a gastroenterologist

When to Seek Urgent Medical Care

Seek immediate medical attention if you experience:

  • Severe abdominal pain
  • High fever
  • Persistent vomiting
  • Signs of bowel obstruction (no stool, severe bloating)
  • Rectal bleeding that is heavy
  • Signs of dehydration

These can be serious or life-threatening and require urgent evaluation.


Final Thoughts

If Humira failed, it does not mean you are out of options.

Today's treatment landscape offers multiple effective alternatives. In many cases, switching to a different class of medication — such as Stelara or Skyrizi — becomes the best medication for Crohn's when Humira fails.

The key is proper evaluation and a thoughtful treatment plan.

Always speak to a doctor or gastroenterologist about persistent flares, medication changes, or any serious or worsening symptoms. Crohn's disease is manageable — but only when treated proactively and carefully.

(References)

  • * Billiet T, Papamichael K, de Vries A, Vande Casteele N, Van Assche G, Ferrante M, Vermeire S, Gils A. Immunogenicity of Adalimumab in Crohn's Disease. Expert Rev Gastroenterol Hepatol. 2016;10(9):983-93. doi: 10.1080/17474124.2016.1197824. PMID: 27367807.

  • * Papamichael K, Vande Casteele N, Ferrante M, Gils A, Van Assche G, Vermeire S. Therapeutic drug monitoring of adalimumab in inflammatory bowel disease: current insights and future directions. Therap Adv Gastroenterol. 2018 Jan;11:1756283X17743952. doi: 10.1177/1756283X17743952. PMID: 29339943; PMCID: PMC5759160.

  • * Sands BE, Sandborn WJ. Crohn's Disease: What to Do When Anti-TNF Therapy Fails. Gastroenterology. 2018 Jan;154(1):16-29. doi: 10.1053/j.gastro.2017.10.024. PMID: 29175373.

  • * Papamichael K, Cheifetz AS, Jairath V, Feagan BG. Optimizing treatment after failure of tumor necrosis factor antagonists in inflammatory bowel disease. Gastroenterology. 2017 Aug;153(2):392-404. doi: 10.1053/j.gastro.2017.06.002. PMID: 28629088.

  • * Ko M, Papamichael K, Nachman F, Ben-Horin S. Current and future therapeutic landscape in inflammatory bowel disease: Moving toward personalized medicine. World J Gastroenterol. 2019 Jul 28;25(28):3737-3759. doi: 10.3748/wjg.v25.i28.3737. PMID: 31409949; PMCID: PMC6684650.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.